2020
DOI: 10.1002/ardp.202000109
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, characterization, molecular docking, and biological activities of coumarin–1,2,3‐triazole‐acetamide hybrid derivatives

Abstract: Coumarins and their derivatives are receiving increasing attention due to numerous biochemical and pharmacological applications. In this study, a series of novel coumarin-1,2,3-triazole-acetamide hybrids was tested against some metabolic enzymes including α-glycosidase (α-Gly), α-amylase (α-Amy), acetylcholinesterase (AChE), butyrylcholinesterase (BChE), human carbonic anhydrase I (hCA I), and hCA II. The new coumarin-1,2,3-triazole-acetamide hybrids showed K i values in the

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
35
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

3
3

Authors

Journals

citations
Cited by 64 publications
(37 citation statements)
references
References 89 publications
2
35
0
Order By: Relevance
“…These are key components of cholinergic brain synapses and neuromuscular connections. [ 38–40 ] The main function of AChE and BChE is to catalyze the hydrolysis of the neurotransmitter ACh and nerve impulse termination at cholinergic synapses. Thus, compounds acting as cholinesterase inhibitors can be considered potential drugs in the treatment of AD, other neurological disorders, and as therapeutic agents.…”
Section: Resultsmentioning
confidence: 99%
“…These are key components of cholinergic brain synapses and neuromuscular connections. [ 38–40 ] The main function of AChE and BChE is to catalyze the hydrolysis of the neurotransmitter ACh and nerve impulse termination at cholinergic synapses. Thus, compounds acting as cholinesterase inhibitors can be considered potential drugs in the treatment of AD, other neurological disorders, and as therapeutic agents.…”
Section: Resultsmentioning
confidence: 99%
“…This disease has two major kinds, type 2‐DM (T2DM, non‐insulin‐dependent diabetes) and type 1‐DM (T1DM, insulin‐dependent diabetes), which the most significant treatment protocols for T1DM is injectable insulin and for T2DM are oral factors like acarbose (glucose uptake reducer in the small intestine), sulfonylurea derivatives (stimulating release of insulin from the β‐cells), troglitazone (improving target cell response to insulin), metformin (insulin resistance reducer), and repaglinide (stimulating release of insulin from the β‐cells). [ 52–54 ]…”
Section: Introductionmentioning
confidence: 99%
“…On the basis of the work of Sharpless and Medal, different copper sources such as Cu (I) [15][16][17][18][19][20], MNP@PIL-Cu [21], Cu-complex [22], Cu NPs [23], and HMS-DP-Cu(II) [24] have been tested. Moreover, in recent years, in order to synthesize triazoles, many other methods have been suggested [25][26][27]. Although these simple procedures are feasible for many reactions, they have a major drawback; when copper salts are used as a homogeneous catalyst, it faces problems such as difficult separation and recycling of the catalyst, cytotoxicity, and environmental pollution.…”
Section: Introductionmentioning
confidence: 99%